FDCDDQ
ADCT icon

Federation des caisses Desjardins du Quebec’s ADC Therapeutics ADCT Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-20
Closed -$63 – 2568
2024
Q2 		$63 Hold
20
– – ﹤0.01% 2405
2024
Q1 		$90 Hold
20
– – ﹤0.01% 2337
2023
Q4 		$33 Hold
20
– – ﹤0.01% 2342
2023
Q3 		$18 Buy
+20
New +$27 ﹤0.01% 2373

Other funds holding ADCT

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's ADCT Position: Q3 2024 in Review

Federation des caisses Desjardins du Quebec sold out of ADC Therapeutics (ADCT) in Q3 2024, closing a stake of 20 shares — an estimated $63 sold.

Federation des caisses Desjardins du Quebec first reported a position in ADCT in Q3 2023 and held it in 4 quarters. The position peaked at $90 in Q1 2024. 77 funds tracked by Wall St. Rank hold ADCT as of Q3 2024.

  • Federation des caisses Desjardins du Quebec reported no remaining ADC Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 20 ADC Therapeutics shares in Q3 2024, an estimated $63.
  • Federation des caisses Desjardins du Quebec first reported a position in ADC Therapeutics in Q3 2023 and held it in 4 quarters.
  • Federation des caisses Desjardins du Quebec's ADC Therapeutics position peaked at $90 in Q1 2024.
  • 77 funds tracked by Wall St. Rank held ADC Therapeutics as of Q3 2024.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2024, filed 13 Nov 2024.